Does ETANERCEPT Cause Hepatocellular carcinoma? 51 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Hepatocellular carcinoma have been filed in association with ETANERCEPT (ENBREL). This represents 0.0% of all adverse event reports for ETANERCEPT.
51
Reports of Hepatocellular carcinoma with ETANERCEPT
0.0%
of all ETANERCEPT reports
7
Deaths
26
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From ETANERCEPT?
Of the 51 reports, 7 (13.7%) resulted in death, 26 (51.0%) required hospitalization, and 11 (21.6%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does ETANERCEPT Cause?
Drug ineffective (60,367)
Rheumatoid arthritis (33,166)
Pain (31,961)
Arthralgia (27,429)
Injection site pain (24,717)
Off label use (20,178)
Fatigue (19,907)
Joint swelling (18,462)
Injection site erythema (17,736)
Condition aggravated (15,897)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which ETANERCEPT Alternatives Have Lower Hepatocellular carcinoma Risk?
ETANERCEPT vs ETANERCEPT-SZZS
ETANERCEPT vs ETELCALCETIDE
ETANERCEPT vs ETEPLIRSEN
ETANERCEPT vs ETESEVIMAB
ETANERCEPT vs ETHACRYNIC ACID